Abstract: A network element of a cable television (CATV) network, said network element comprising a distributed access node comprising a core network interface for receiving a plurality of broadcast multiplexes; means for dividing the plurality of broadcast multiplexes into at least a first transmission content and a second transmission content, wherein the first and the second transmission content comprise at least partly different multiplexes; and means for transmitting the first transmission content to a first network segment and the second transmission content to a second network segment.

Abstract: The invention relates to a combination of (a) an inhibitor of platelet-derived growth factor (PDGF) activity and (b) a vector for vascular endothelial growth factor (VEGF-, especially VEGF-C) gene transfer, a pharmaceutical preparation comprising (a) and (b) in combination together with a pharmaceutically acceptable carrier material; a product comprising (a) and (b) as defined above and optionally a pharmaceutically acceptable carrier material, for simultaneous, chronologically staggered or separate use; a method of administering or the use of said combination or product for the treatment of endothelial damage; and/or to the use of (a) and (b) for the manufacture of said pharmaceutical preparation or product for the treatment of endothelial damage.